From: Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art
 | After-treatment-phase | Early-Phase | Intermediate-phase | Late-phase |
---|---|---|---|---|
Successful treatment | Consolidative center surrounded by a peripheral ground-glass area > 5 mm | The peripheral ground-glass opacity evolves into a thin consolidative area The resulting consolidation is typically more extensive than the original tumor | Progressive decrease in the size of the treated area Persistence of a benign periablational enhancement, yet less than the original tumor | Three to six months after ablation: stability in size. After six months: progressive decrease in size Increased enhancement compared to previous phases may exist |
Unsuccessful treatment | Irregular peripheral nodular enhancement within the consolidative center | Excessive growth of the treated area Irregular and peripheral enhancement or within central consolidation | PET/TC: solitary focal or peripheral FDG uptake or combined with a focal uptake at the consolidative center | Enlargement of the treated area after the first three months that persists beyond six months Any FDG uptake suggests recurrence |